It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...

One expert explains what patients with prostate cancer interested in clinical trial participation need to know. For patients with prostate cancer who are interested in participating in clinical trials ...

Prostate massages are a fairly unexplored thing for most men. Society isn’t exactly a judgment-free space, and the stigma associated with using prostate massagers can make it feel wrong to explore the ...

An FDA advisory panel has voted 7-1, with one abstention, to recommend expanding the use of AstraZeneca’s capivasertib (Truqap) for PTEN-deficient metastatic hormone-sensitive prostate cancer. The ...

New research suggests that men who take multivitamins after being diagnosed with prostate cancer may have a lower risk of cancer recurrence. In the overall study group, current multivitamin users ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy. Combining gene therapy ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track ...